187 related articles for article (PubMed ID: 12388139)
1. Intramyocellular lipid accumulation and reduced whole body lipid oxidation in HIV lipodystrophy.
Luzi L; Perseghin G; Tambussi G; Meneghini E; Scifo P; Pagliato E; Del Maschio A; Testolin G; Lazzarin A
Am J Physiol Endocrinol Metab; 2003 Feb; 284(2):E274-80. PubMed ID: 12388139
[TBL] [Abstract][Full Text] [Related]
2. Effect of L-acetylcarnitine on body composition in HIV-related lipodystrophy.
Benedini S; Perseghin G; Terruzzi I; Scifo P; Invernizzi PL; Del Maschio A; Lazzarin A; Luzi L
Horm Metab Res; 2009 Nov; 41(11):840-5. PubMed ID: 19598076
[TBL] [Abstract][Full Text] [Related]
3. Total energy expenditure and carbohydrate oxidation are increased in the human immunodeficiency virus lipodystrophy syndrome.
Kosmiski LA; Kuritzkes DR; Sharp TA; Hamilton JT; Lichtenstein KA; Mosca CL; Grunwald GK; Eckel RH; Hill JO
Metabolism; 2003 May; 52(5):620-5. PubMed ID: 12759894
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of metabolic syndrome in HIV-infected patients receiving highly active antiretroviral therapy using International Diabetes Foundation and Adult Treatment Panel III criteria: associations with insulin resistance, disturbed body fat compartmentalization, elevated C-reactive protein, and [corrected] hypoadiponectinemia.
Samaras K; Wand H; Law M; Emery S; Cooper D; Carr A
Diabetes Care; 2007 Jan; 30(1):113-9. PubMed ID: 17192343
[TBL] [Abstract][Full Text] [Related]
5. Liver triglyceride content in HIV-1-infected patients on combination antiretroviral therapy studied with 1H-MR spectroscopy.
Moreno-Torres A; Domingo P; Pujol J; Blanco-Vaca F; Arroyo JA; Sambeat MA
Antivir Ther; 2007; 12(2):195-203. PubMed ID: 17503662
[TBL] [Abstract][Full Text] [Related]
6. Metabolic basis of HIV-lipodystrophy syndrome.
Sekhar RV; Jahoor F; White AC; Pownall HJ; Visnegarwala F; Rodriguez-Barradas MC; Sharma M; Reeds PJ; Balasubramanyam A
Am J Physiol Endocrinol Metab; 2002 Aug; 283(2):E332-7. PubMed ID: 12110539
[TBL] [Abstract][Full Text] [Related]
7. Normal insulin sensitivity and IMCL content in overweight humans are associated with higher fasting lipid oxidation.
Perseghin G; Scifo P; Danna M; Battezzati A; Benedini S; Meneghini E; Del Maschio A; Luzi L
Am J Physiol Endocrinol Metab; 2002 Sep; 283(3):E556-64. PubMed ID: 12169449
[TBL] [Abstract][Full Text] [Related]
8. Insulin action, regional fat, and myocyte lipid: altered relationships with increased adiposity.
Gan SK; Kriketos AD; Poynten AM; Furler SM; Thompson CH; Kraegen EW; Campbell LV; Chisholm DJ
Obes Res; 2003 Nov; 11(11):1295-305. PubMed ID: 14627749
[TBL] [Abstract][Full Text] [Related]
9. Increased intramyocellular lipid accumulation in HIV-infected women with fat redistribution.
Torriani M; Thomas BJ; Barlow RB; Librizzi J; Dolan S; Grinspoon S
J Appl Physiol (1985); 2006 Feb; 100(2):609-14. PubMed ID: 16223978
[TBL] [Abstract][Full Text] [Related]
10. The effect of rosiglitazone on insulin sensitivity, beta cell function, bone mineral density, and body composition in hiv-positive patients on highly-active antiretroviral therapy (HAART).
Schindler K; Rieger A; Tura A; Gmeinhardt B; Touzeau-Römer V; Haider D; Pacini G; Ludvik B
Horm Metab Res; 2009 Jul; 41(7):573-9. PubMed ID: 19322744
[TBL] [Abstract][Full Text] [Related]
11. Insulin resistance and whole body energy homeostasis in obese adolescents with fatty liver disease.
Perseghin G; Bonfanti R; Magni S; Lattuada G; De Cobelli F; Canu T; Esposito A; Scifo P; Ntali G; Costantino F; Bosio L; Ragogna F; Del Maschio A; Chiumello G; Luzi L
Am J Physiol Endocrinol Metab; 2006 Oct; 291(4):E697-703. PubMed ID: 16684857
[TBL] [Abstract][Full Text] [Related]
12. Altered fat differentiation and adipocytokine expression are inter-related and linked to morphological changes and insulin resistance in HIV-1-infected lipodystrophic patients.
Jan V; Cervera P; Maachi M; Baudrimont M; Kim M; Vidal H; Girard PM; Levan P; Rozenbaum W; Lombès A; Capeau J; Bastard JP
Antivir Ther; 2004 Aug; 9(4):555-64. PubMed ID: 15456087
[TBL] [Abstract][Full Text] [Related]
13. Adipocyte-derived hormone levels in HIV lipodystrophy.
Kosmiski L; Kuritzkes D; Lichtenstein K; Eckel R
Antivir Ther; 2003 Feb; 8(1):9-15. PubMed ID: 12713059
[TBL] [Abstract][Full Text] [Related]
14. Increased systemic and adipose tissue cytokines in patients with HIV-associated lipodystrophy.
Johnson JA; Albu JB; Engelson ES; Fried SK; Inada Y; Ionescu G; Kotler DP
Am J Physiol Endocrinol Metab; 2004 Feb; 286(2):E261-71. PubMed ID: 14532165
[TBL] [Abstract][Full Text] [Related]
15. [Adipokines and highly active antiretroviral therapy related lipodystrophy: clinical study of 52 cases].
Tao MM; Zhang L; Qiu ZF; Xie J; Han Y; Yu W; Li M; Li TS
Zhonghua Yi Xue Za Zhi; 2009 Apr; 89(13):867-71. PubMed ID: 19671283
[TBL] [Abstract][Full Text] [Related]
16. Increased resting energy expenditure, fat oxidation, and food intake in patients with highly active antiretroviral therapy-associated lipodystrophy.
Sutinen J; Yki-Järvinen H
Am J Physiol Endocrinol Metab; 2007 Mar; 292(3):E687-92. PubMed ID: 17062843
[TBL] [Abstract][Full Text] [Related]
17. Metabolic regulation of growth hormone by free fatty acids, somatostatin, and ghrelin in HIV-lipodystrophy.
Koutkia P; Meininger G; Canavan B; Breu J; Grinspoon S
Am J Physiol Endocrinol Metab; 2004 Feb; 286(2):E296-303. PubMed ID: 14559725
[TBL] [Abstract][Full Text] [Related]
18. Rosiglitazone in the treatment of HAART-associated lipodystrophy--a randomized double-blind placebo-controlled study.
Sutinen J; Häkkinen AM; Westerbacka J; Seppälä-Lindroos A; Vehkavaara S; Halavaara J; Järvinen A; Ristola M; Yki-Järvinen H
Antivir Ther; 2003 Jun; 8(3):199-207. PubMed ID: 12924536
[TBL] [Abstract][Full Text] [Related]
19. Plasminogen activator inhibitor type 1 (PAI-1) in plasma and adipose tissue in HIV-associated lipodystrophy syndrome. Implications of adipokines.
He G; Andersen O; Haugaard SB; Lihn AS; Pedersen SB; Madsbad S; Richelsen B
Eur J Clin Invest; 2005 Sep; 35(9):583-90. PubMed ID: 16128865
[TBL] [Abstract][Full Text] [Related]
20. Tumor necrosis factor alpha is associated with insulin-mediated suppression of free fatty acids and net lipid oxidation in HIV-infected patients with lipodystrophy.
Haugaard SB; Andersen O; Pedersen SB; Dela F; Fenger M; Richelsen B; Madsbad S; Iversen J
Metabolism; 2006 Feb; 55(2):175-82. PubMed ID: 16423623
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
